The FDA released a guidance for
industry on Nov. 22 describing how
contract manufacturing organizations
can use quality agreements to delineate
their manufacturing activities to ensure
compliance with current GMPs.
According to this document, companies
outsourcing pharmaceutical operations
are responsible for the quality of the final
product, not the outsourcing firm.
Comments on the guidance are due at any